Search

Displaying results 5791 - 5800 of 9670 in total
  1. Drug

    Prostaglandin G2

    go.drugbank.com/drugs/DB03866
    Experimental

    It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]

  2. Drug

    Eritoran

    go.drugbank.com/drugs/DB04933
    Investigational

    It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

  3. Drug

    Fulzerasib

    go.drugbank.com/drugs/DB21609
    Investigational

    Fulzerasib has a monoisotopic molecular weight of 630.22 Da. … The usage of the INN stem '-rasib' in the name indicates that Fulzerasib is a Ras protein inhibitor.

  4. Drug

    Reloxiliase

    go.drugbank.com/drugs/DB17653
    Experimental

    It is being investigated for the treatment of hyperoxaluria.[A258823]

  5. Drug

    WP-1301

    go.drugbank.com/drugs/DB17702
    Experimental

    It binds to an MHC class II molecule and is recognized by a Factor VIII-specific T cell.[L46138]

  6. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    It is under investigation for the treatment of growth hormone deficiency.

  7. Drug

    Socazolimab

    go.drugbank.com/drugs/DB18845
    Investigational

    Socazolimab is under investigation in clinical trial NCT04878016 (A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-pd-l1 Antibody) in Patients With ES-SCLC).

  8. Drug

    Elzovantinib

    go.drugbank.com/drugs/DB18918
    Investigational

    Elzovantinib is under investigation in clinical trial NCT03993873 (Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET).

  9. Drug

    NOP-1A

    go.drugbank.com/drugs/DB15208
    Investigational

    NOP-1A is under investigation in clinical trial NCT01198197 (PET Brain and Whole Body Distribution Studies for Nociceptin/Orphanin FQ Peptide (NOP) Receptor Using [11C]NOP-1A).

  10. Drug

    Dimethylcurcumin

    go.drugbank.com/drugs/DB06133
    Investigational

    It is a novel anti-androgen that enhances androgen receptor degradation.